Rhabdomyosarcoma in Children

Childhood rhabdomyosarcoma (also called "rhabd" or RMS) is a tumor in which malignant (cancer) cells look like young immature myocytes. It is the most common soft tissue sarcoma of children (soft tissue and connective tissue cancer). In the United States, approximately 350 new cases are diagnosed as children under the age of 20 every year. Almost two-thirds of cases of rhabdomyosarcoma of children are diagnosed as children

Urogenital (urogenital system) includes soft tissues surrounding bladder, vagina, prostate and testis.

Rhabdomyosarcoma accounts for approximately 3% of childhood cancers. About 350 children are diagnosed with rhabdomyosarcoma every year in the United States. The disease mainly affects children under 10 years of age, but it can develop at any age. For unknown reasons men are slightly affected by women. Several rhabdomyosarcoma tumors are thought to begin to develop in the fetus. Striated muscle cells are the cells in the early development of the fetus. These cells mature and grow into muscles. Many studies have been done on the genetic structure of these striated muscle cells and it is possible to detect genetic errors that can cause disease in later stages of development.

Childhood rhabdomyosarcoma (also called "rhabd" or RMS) is a tumor in which malignant (cancer) cells look like young immature myocytes. It is the most common soft tissue sarcoma of children (soft tissue and connective tissue cancer). In the United States, approximately 350 new cases are diagnosed as children under the age of 20 every year. Almost two-thirds of cases of rhabdomyosarcoma of children are diagnosed as children

Rhabdomyosarcoma usually has some chromosomal abnormality in tumor cells involved in tumorigenesis. Children with fetal rhabdomyosarcoma usually have chromosome 11 abnormality. In alveolar rhabdomyosarcoma, there is usually a rearrangement of chromosomal material between chromosome 2 and 13. This rearrangement changes the position and function of the gene, causing the fusion of genes called fusion transcripts. The patient has an abnormal fusion transcript containing two genes called PAX3 and FKHR. This important finding promotes the diagnosis of rhabdomyosarcoma

Undifferentiated (undifferentiated) rhabdomyosarcoma, also known as polymorphic rhabdomyosarcoma, is the last variant of RMS that is recognized in most classification systems. Undifferentiated rhabdomyosarcoma is defined as the presence of undifferentiated cells with large leafy chromatin nuclei and multipolar mitotic maps. These tumors show high heterogeneity and poor differentiation. Undifferentiated cells can be diffuse or focal, and diffuse changes are associated with poor prognosis. It happens most frequently in adults, rarely in children, and is often seen in limbs. Due to the lack of identifiable separation during this type of cancer, clinicians often classify sarcomas that have not been diagnosed as undifferentiated RMS with little or no distinctive features. It is the most aggressive RMS and usually requires intensive care